
Keywords: coronary artery bypass grafting; diabetes mellitus type 1; glycosylated hemoglobin A; prognosisCABG, coronary artery bypass grafting; CHD, coronary heart disease; CVD, cardiovascular disease; HbA1c, hemoglobin A1c; MACE, major adverse cardiovascular event